Top Pharma API and Finished Dosage Formulators

Quick visualization of US FDA audited companies have been captured in info-graphics GDUFAbelow. Regulatory data have been used as feed stock for these deductions.

Trailblazers across various areas have been highlighted in visualization. Some of the major observations have been outlined below:

  1.  Year 2016 witnessed dip in overall FDA audited facility counts.
  2. While Sanofi led the FDA approved facility count in API space, Mylan was forerunner in finished dosage segment.
  3. India witnessed highest facility count increase in API space, while Taiwan enjoyed  number 1 position in terms of increase in FDF approved facilities for the year trailing 2016-2017.

Note: Analysis was carried on data sets which was not very organized at company name level, hence some of the prominent entries might be missing from visualization.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s